We Accept amex

Formerly known as Maylips.com

info@directdoctorsupply.com+1-800-325-7104

Logo Logo
Track delivery Wishlist
  • 0 $ 0.00
  • Products
    • All Products
    • Peptides NEW
    • Anaesthetics
    • Body Sculpting
    • Botulinum Toxin
    • Cannulas and Needles
    • Cellular Rejuvenation
    • Dermal Filler Removal
    • Dermal Fillers
      • Biostimulators
      • HA Dermal Fillers
      • Korean Dermal Fillers
      • Polynucleotides
      • Skinboosters
    • Exosomes
    • Eyelash Enhancers
    • Fat Removal
    • Gynecology
    • Mesotherapy
    • IV Therapy
    • Orthopedic Injections
    • Peels and Masks
    • PRP Kits
    • Skincare
    • Threads
      • PCLA Threads
      • PDO Threads
      • PLA Threads
    • Weight Loss
  • Brands
    • ALIAXIN®
    • ALIDYA™
    • AQUALYX®
    • AZZALURE®
    • BCN
    • BELLAST®
    • BELOTERO®
    • BIOREPEELCL3®
    • BOCOUTURE® (XEOMIN®)
    • BOTOX®
    • CAREGEN
    • CINGAL®
    • CRESPINE®
    • CROMA
    • CYTOCARE
    • DEPO-PROVERA®
    • DERMALAX™
    • DESIRIAL®
    • DUROLANE®
    • DYSPORT®
    • EJAL
    • ELLANSÉ™
    • EMLA™
    • Euflexxa
    • FILLMED®
    • FILORGA®
    • GARDASIL®
    • HArmonyCA™
    • HYACORP
    • HYAFILIA®
    • HYALGAN®
    • HYMOVIS®
    • HYNIDASE®
    • INTRALINE®
    • JALUPRO®
    • JAYDESS®
    • JUVÉDERM®
    • KARISMA
    • LEMONBOTTLE
    • LANLUMA
    • LIPORASE®
    • MEDIDERMA®
    • MESO-RELLE®
    • MESOESTETIC®
    • MICRONJET™
    • MIRENA®
    • MONOVISC®
    • MOUNJARO®
    • NEAUVIA™
    • NEURAMIS®
    • NEXPLANON®
    • NITHYA
    • NOVERA COMPOUNDS
    • NUCLEOFILL™
    • ORTHOVISC®
    • OZEMPIC®
    • PERFECTHA®
    • PLASMOLIFTING™
    • PROFHILO®
    • ​PROSTROLANE®
    • PRX-T33®
    • RADIESSE®
    • RAINBOW
    • REFINE
    • REJURAN®
    • REJUVANAD+
    • REFINE
    • RESTYLANE®
    • REVANESSE®
    • REVOFIL
    • REVOLAX™
    • SAXENDA®
    • SAYPHA®
    • SCULPTRA®
    • SESDERMA®
    • SILHOUETTE
    • SMB®
    • SOFTFIL®
    • STYLAGE®
    • SUNEKOS®
    • SUPARTZ®
    • SYNVISC®
    • T-SAFE®
    • TEOSYAL®
    • ​THERASET®
    • VISCODERM®
    • WEGOVY®
    • XEOMIN®
    • ZO®
  • Peptides NEW
  • Sale
  • Shipping
  • Contact
  • About Us
  • Referral Program
  • Blog
  • Sign In / Register
Logo Logo
Menu
Close
Wishlist
  • Products
    • All Products
    • Peptides NEW
    • Anaesthetics
    • Body Sculpting
    • Botulinum Toxin
    • Cannulas and Needles
    • Cellular Rejuvenation
    • Dermal Filler Removal
    • Dermal Fillers
      • Biostimulators
      • HA Dermal Fillers
      • Korean Dermal Fillers
      • Polynucleotides
      • Skinboosters
    • Exosomes
    • Eyelash Enhancers
    • Fat Removal
    • Gynecology
    • Mesotherapy
    • IV Therapy
    • Orthopedic Injections
    • Peels and Masks
    • PRP Kits
    • Skincare
    • Threads
      • PCLA Threads
      • PDO Threads
      • PLA Threads
    • Weight Loss
  • Brands
    • ALIAXIN®
    • ALIDYA™
    • AQUALYX®
    • AZZALURE®
    • BCN
    • BELLAST®
    • BELOTERO®
    • BIOREPEELCL3®
    • BOCOUTURE® (XEOMIN®)
    • BOTOX®
    • BOTULAX®
    • CAREGEN
    • CINGAL®
    • CRESPINE®
    • CROMA
    • CYTOCARE
    • DEPO-PROVERA®
    • DERMALAX™
    • DESIRIAL®
    • DUROLANE®
    • DYSPORT®
    • EJAL
    • ELLANSÉ™
    • EMLA™
    • Euflexxa
    • FILLMED®
    • FILORGA®
    • GARDASIL®
    • HArmonyCA™
    • HYACORP
    • HYAFILIA®
    • HYALGAN®
    • HYMOVIS®
    • HYNIDASE®
    • INNOTOX®
    • INTRALINE®
    • JALUPRO®
    • JAYDESS®
    • JUVÉDERM®
    • KAIMAX
    • KARISMA
    • LEMONBOTTLE
    • LETYBO®
    • LANLUMA
    • LIPORASE®
    • LIZTOX®
    • MEDIDERMA®
    • MEDITOXIN®
    • MESO-RELLE®
    • MESOESTETIC®
    • MICRONJET™
    • MIRENA®
    • MONOVISC®
    • MOUNJARO®
    • NABOTA® (JEUVEAU®)
    • NEAUVIA™
    • NEURAMIS®
    • NEXPLANON®
    • NITHYA
    • NOVERA COMPOUNDS
    • NUCLEOFILL™
    • ORTHOVISC®
    • OZEMPIC®
    • PERFECTHA®
    • PLASMOLIFTING™
    • PROFHILO®
    • ​PROSTROLANE®
    • PRX-T33®
    • RADIESSE®
    • RAINBOW
    • Re N Tox™
    • REFINE
    • REJURAN®
    • REJUVANAD+
    • REFINE
    • RESTYLANE®
    • REVANESSE®
    • REVOFIL
    • REVOLAX™
    • SAXENDA®
    • SAYPHA®
    • SCULPTRA®
    • SESDERMA®
    • SILHOUETTE
    • SMB®
    • SOFTFIL®
    • STYLAGE®
    • SUNEKOS®
    • SUPARTZ®
    • SYNVISC®
    • T-SAFE®
    • TEOSYAL®
    • ​THERASET®
    • VISCODERM®
    • WEGOVY®
    • XEOMIN®
    • ZO®
  • Peptides NEW
  • Sale
  • Shipping
  • Contact
  • About Us
  • Referral Program
  • Blog
  • Sign In / Register
  • 0 $ 0.00
Direct Doctor SupplyProduct BrandsHYALGAN®
Product Category
  • Anaesthetics (2)
  • Body Sculpting (4)
  • Botulinum Toxins (33)
  • Cannulas and Needles (13)
  • Cellular Rejuvenation (1)
  • Dermal Filler Removal (2)
  • Dermal Fillers (192)
  • Biostimulators (10)
  • HA Dermal Fillers (129)
  • Korean Dermal Fillers (28)
  • Polynucleotides (17)
  • Skinboosters (16)
  • Exosomes (1)
  • Eyelash Enhancers (1)
  • Fat Removal (3)
  • Gynecology (8)
  • IV Therapy (2)
  • Mesotherapy (23)
  • Orthopedic Injections (11)
  • Peels and Masks (23)
  • Peptides for Research (45)
  • Aesthetic & Cosmetic Peptides (1)
  • Brain, Cognitive & Nootropic Peptides (4)
  • Healing & Regenerative Peptides (6)
  • Immune & Thymic Peptides (4)
  • Longevity & Anti-Aging Peptides (7)
  • Muscle Growth & Performance Peptides (11)
  • Sexual Health & Hormonal Peptides (3)
  • Weight Loss & Metabolic Peptides (11)
  • PRP Kits (1)
  • Skincare (26)
  • Threads (28)
  • PCLA Threads (3)
  • PDO Threads (20)
  • PLA Threads (3)
  • Weight Loss (24)
Product Brand
  • ALIAXIN® (6)
  • ALIDYA™ (1)
  • AQUALYX® (1)
  • AZZALURE® (1)
  • BCN (12)
  • BELLAST® (3)
  • BELOTERO® (7)
  • BIOMEDICO (3)
  • BIOREPEELCL3® (2)
  • BOCOUTURE® (XEOMIN®) (3)
  • BOTOX® (6)
  • CAREGEN (2)
  • CINGAL® (1)
  • CRESPINE® (1)
  • CROMA (4)
  • CYTOCARE (4)
  • DEPO-PROVERA® (1)
  • DERMALAX™ (3)
  • DESIRIAL® (2)
  • DUROLANE® (1)
  • DYSPORT® (4)
  • EJAL (1)
  • ELLANSÉ™ (2)
  • EMLA™ (2)
  • EUFLEXXA® (1)
  • EXOJUV (1)
  • FILLMED® (14)
  • FILORGA® (2)
  • GARDASIL® (1)
  • HArmonyCA™ (1)
  • HYACORP (5)
  • HYAFILIA® (2)
  • HYALGAN® (1)
  • HYMOVIS® (1)
  • HYNIDASE® (1)
  • INTRALINE® (24)
  • JALUPRO® (5)
  • JAYDESS® (1)
  • JUVÉDERM® (13)
  • KARISMA (1)
  • LANLUMA (1)
  • LEMONBOTTLE (1)
  • LIPORASE® (1)
  • MEDIDERMA® (26)
  • MESO-RELLE® (2)
  • MESOESTETIC® (2)
  • MICRONJET™ (1)
  • MIRENA® (1)
  • MONOVISC® (1)
  • MOUNJARO® (9)
  • NEAUVIA™ (11)
  • NEURAMIS® (1)
  • NEXPLANON® (2)
  • NITHYA (3)
  • NOVERA COMPOUNDS (46)
  • NUCLEOFILL™ (8)
  • ORTHOVISC® (1)
  • OZEMPIC® (8)
  • PERFECTHA® (4)
  • PLASMOLIFTING™ (1)
  • PLINEST® (5)
  • PROFHILO® (3)
  • ​PROSTROLANE® (1)
  • PRX-T33® (1)
  • RADIESSE® (3)
  • RAINBOW (7)
  • REFINE (3)
  • REJURAN® (3)
  • REJUVANAD+ (2)
  • RENEFIL (3)
  • RESTYLANE® (10)
  • REVANESSE® (6)
  • REVOFIL (9)
  • REVOLAX™ (4)
  • SAXENDA® (1)
  • SAYPHA® (6)
  • SCULPTRA® (1)
  • SESDERMA® (10)
  • SILHOUETTE (3)
  • SMB® (1)
  • SOFTFIL® (6)
  • STYLAGE® (25)
  • SUNEKOS® (4)
  • SUPARTZ® (1)
  • SYNVISC® (2)
  • T-SAFE® (1)
  • TEOSYAL® (12)
  • ​THERASET® (1)
  • ULTRA V® (1)
  • VISCODERM® (2)
  • WEGOVY® (6)
  • XEOMEEN® (1)
  • XEOMIN® (4)
  • ZO® (3)

Buy HYALGAN®

Showing the single result

Sort By:
  • HYALGAN 1SYRINGE ENGLISH 01HYALGAN 1SYRINGE ENGLISH 01
    HYALGAN® (English Alternative)
    $ 49.00
    Add To Cart
    -+

HYALGAN® is an FDA-approved avian-derived sodium hyaluronate viscosupplement manufactured by Fidia Pharma, indicated for the treatment of painful osteoarthritis of the knee in patients who have not responded adequately to conservative therapy and simple analgesics. Supplied as a 20 mg/2 mL pre-filled syringe for intra-articular injection, it is backed by decades of controlled clinical trial evidence and billed under Medicare J-code J7321. Direct Doctor Supply has supplied licensed practitioners with orthopedic injectables including HYALGAN® since 2014.

About the Manufacturer — Fidia Pharma

Fidia Pharma was founded in 1946 in Abano Terme, Italy, and has developed into one of the most specialized manufacturers in hyaluronic acid research and production. The company’s focus spans orthopedics, ophthalmology, wound care, and aesthetic medicine, reflecting deep expertise in HA-based medical technologies and the future of hyaluronans across therapeutic applications.

HYALGAN® is a cornerstone of Fidia Pharma’s orthopedic portfolio. Its broader HA range also includes Hyalubrix and Sinovial, providing context for the depth of formulation experience and manufacturing capability that underpins HYALGAN® as a viscosupplement product.

Who Is HYALGAN® For? — Knee OA Indications and Patient Profile

HYALGAN® is FDA-approved for the treatment of painful osteoarthritis of the knee in patients who have not achieved adequate relief from conservative non-pharmacologic therapy and simple analgesics [4][5]. Its labeled indication is limited to the knee joint.

Candidates typically present with one or more of the following:

  • Symptomatic knee osteoarthritis with ongoing pain affecting function and quality of life.
  • Insufficient response to physiotherapy, weight management, activity modification, or oral analgesics.
  • A preference to avoid or delay long-term NSAID use or surgical intervention.
  • A knee with joint effusion that can be aspirated before injection, which does not contraindicate treatment [4].

HYALGAN® is a medical device, not a steroid or analgesic drug [4][5]. Practitioners should confirm patient eligibility against the current labeled indication and IFU before initiating treatment.

How HYALGAN® Works — Intra-Articular Sodium Hyaluronate

In healthy joints, hyaluronic acid within the synovial fluid provides lubrication and shock absorption during movement. As osteoarthritis progresses, both the concentration and quality of endogenous HA decline, reducing the fluid’s ability to protect cartilage surfaces and cushion the joint [1].

HYALGAN® is injected directly into the knee joint to supplement naturally occurring HA and restore the viscoelastic properties of synovial fluid that are diminished by osteoarthritis [1][4]. This is intra-articular treatment with sodium hyaluronate rather than a corticosteroid or pharmacological approach: it functions by improving joint lubrication and reducing the mechanical friction associated with cartilage degradation. HYALGAN® ingredients include avian-derived sodium hyaluronate (500–730 kDa) and phosphate-buffered saline; it contains no cross-linking agents, corticosteroids, or local anesthetics [4]. Because the formulation is a viscous HA solution, some clinic teams informally refer to HYALGAN® gel injections, though the product is a non-cross-linked sodium hyaluronate rather than a cross-linked gel.

HYALGAN® is classified as a medical device under FDA regulation, not a pharmaceutical drug [4][5]. Its mechanism is mechanical and biological rather than pharmacological. The Altman and Moskowitz HYALGAN® study group RCT remains the foundation of the product’s clinical evidence for intra-articular sodium hyaluronate in knee osteoarthritis [1].

About HYALGAN® — An Established Sodium Hyaluronate Viscosupplement

HYALGAN® is one of the most extensively documented sodium hyaluronate viscosupplements in clinical use. Its avian-derived formulation, sourced from rooster comb at a molecular weight of 500–730 kDa, has been evaluated across multiple randomized controlled trials and long-term studies since its FDA approval [1][3][4]. The evidence base includes the landmark Altman and Moskowitz randomized controlled trial, which enrolled 495 patients and demonstrated sustained pain relief and functional improvement through 26 weeks [1].

That long clinical history, combined with an established Medicare billing pathway, has kept HYALGAN® a familiar option among practitioners managing HYALGAN® in patients with osteoarthritis of the knee. It remains a non-cross-linked reference point against which many newer viscosupplements are compared.

HYALGAN® Product Spotlight

The HYALGAN® 20 mg/mL, 2 mL prefilled syringe contains avian-derived sodium hyaluronate (500–730 kDa) in a phosphate-buffered saline solution, supplied ready for intra-articular injection without reconstitution [4].

HYALGAN® injection dosage is 2 mL per session, administered directly into the knee joint. The labeled course is five weekly intra-articular injections [4]. Clinical data support that some patients may achieve comparable outcomes with a three-injection regimen: a 2017 meta-analysis involving 2,168 participants found similar pain relief outcomes with three- and five-week HYALGAN® treatment courses [2]. This evidence on the efficacy of different dose schedules allows clinicians to tailor treatment to individual patient needs and clinical context.

For clinics weighing procurement, HYALGAN® injection price depends on order volume and account terms rather than a single list figure, and current pricing can be confirmed with the Direct Doctor Supply support team. Long-term follow-up data further support HYALGAN®’s place in repeat treatment planning [3]. Fidia Pharma’s broader HA portfolio, including Hyalubrix and Sinovial, reflects the manufacturing depth behind this product.

Why Practitioners Choose HYALGAN®

  • Scope and Duration of Clinical Evidence Base: HYALGAN® has been evaluated in multiple controlled clinical trials, including the Altman and Moskowitz HYALGAN® study group RCT, the Jubb et al. one-year randomized placebo-controlled trial, and the Strand et al. systematic review and meta-analysis comparing three- and five-injection course outcomes [1][2][3]. That range spans a controlled single-blind trial design through long-term efficacy and safety follow-up, giving practitioners a broad and durable foundation for viscosupplementation decisions. For those weighing HYALGAN® injection alternatives, this depth of published data is often the deciding factor.
  • Well-Established Reimbursement Pathway: HYALGAN® is billed under J-code J7321, a recognized CMS designation with a long billing history under Medicare viscosupplementation criteria. For clinic teams, working with a familiar J-code can reduce administrative burden compared with newer or less established codes. All billing and coding should be verified against current CMS guidance and applicable local coverage determinations before claim submission.

Administration — Injection Protocol and Aftercare

HYALGAN® knee injections are administered intra-articularly into the knee joint space using standard aseptic technique. The presence of a knee with joint effusion does not contraindicate treatment; any effusion should be aspirated before injection to optimize joint space and reduce dilution of the dose [4]. HYALGAN® is injected directly into the knee once weekly. The labeled course is five injections, and clinical evidence supports a three-injection course as a viable alternative for appropriate patients [2][4]. Because dose schedules of hyaluronic acid vary in the literature, practitioners should refer to the current IFU and relevant clinical studies when determining the schedule for individual patients.

Start of Effects

Patients frequently ask whether HYALGAN® injections are painful. Mild discomfort is typical of any intra-articular procedure; patients may experience transient pressure or soreness during and briefly after injection. In the pivotal RCT, HYALGAN® was described as generally well tolerated, with injection-site reactions mild and transient [1]. Use of local anesthetic prior to injection is at the practitioner’s discretion.

HYALGAN®’s onset varies between patients. In the Altman and Moskowitz RCT, meaningful pain reduction was observed at multiple time points across the 26-week follow-up period [1]. HYALGAN® is not an immediate-onset analgesic; practitioners should counsel patients that full benefit may take several weeks to become apparent.

Distribution and Market Availability

HYALGAN® is distributed through authorized medical device supply channels across the United States and several international markets. As an FDA-approved device, it is subject to the regulatory requirement that it be sold by or on the order of a physician [5]. Any distributor should confirm documented handling and reliable shipping timelines before delivery is accepted.

Direct Doctor Supply has been a trusted wholesale supplier of orthopedic injectables since 2014. Practitioners can buy HYALGAN® online through the Direct Doctor Supply catalog, with support staff available for product queries, bulk order logistics, and order tracking. Practitioners sourcing across multiple categories can also buy orthopedic injections from the same professional wholesale platform, and multi-specialty practices can buy dermal fillers there as well.

Regulatory Status, J-Code, and Coverage

HYALGAN® holds FDA approval under Premarket Approval (PMA) P950027 for the treatment of pain from knee osteoarthritis in patients who have not adequately responded to conservative non-pharmacological therapy and simple analgesics [5]. It is regulated as a medical device, not as a pharmaceutical drug [4][5].

  • HYALGAN® J code: The designated billing code is J7321, used for intra-articular sodium hyaluronate injections on a per-dose basis. J7321 is one of the most established codes in the viscosupplement billing category, reflecting HYALGAN®’s long tenure as an FDA-approved device.
  • HYALGAN® injection CPT code: The injection procedure is typically billed under CPT code 20610 for arthrocentesis or intra-articular injection of a major joint. Practitioners should verify current CMS and payer-specific coding requirements with their billing team before claim submission, as CPT guidance may be updated periodically.

HYALGAN® Medicare Coverage

Coverage may be available when applicable Medicare viscosupplementation criteria are met. Practitioners should verify current local coverage determinations and individual patient eligibility before initiating treatment, as coverage requirements are subject to change.

HYALGAN® vs Competing Viscosupplements

HYALGAN® vs ORTHOVISC®

ORTHOVISC® is produced via bacterial fermentation and carries no avian-derived material, which eliminates the pre-treatment avian allergy screening that HYALGAN® requires as a rooster-comb-sourced product [4]. Its molecular weight range is substantially higher than HYALGAN®’s 500–730 kDa, and it is typically given over three to four weekly injections. Clinics that treat avian-sensitive patients often buy ORTHOVISC® for exactly that group, reserving HYALGAN® for cases where allergy screening is straightforward.

HYALGAN® vs EUFLEXXA®

EUFLEXXA® is a non-avian, biofermentation-derived sodium hyaluronate with a substantially higher molecular weight than HYALGAN®, given as a three-injection course. Practices that have moved away from avian-sourced products tend to buy EUFLEXXA® as their default and keep HYALGAN® for patients already established on it. What HYALGAN® retains is the longer published clinical record across multiple controlled trial datasets, which can matter in payer environments where evidence depth and billing familiarity weigh on the decision [4].

HYALGAN® vs MONOVISC®

MONOVISC® is a non-avian, cross-linked HA viscosupplement delivered in a single injection, the most convenient course format in the category. That convenience is the usual reason a practice would buy MONOVISC® for a given patient, though the single-dose format gives up something HYALGAN®’s multi-injection course preserves: effusion aspiration and clinical monitoring at each visit across the treatment period. The Direct Doctor Supply catalog carries both for practices that want to keep the option open.

HYALGAN® vs SYNVISC®

Both HYALGAN® and SYNVISC® are avian-derived and share the same label-based pre-treatment avian allergy screening requirement [4]. The distinction is compositional: SYNVISC® (hylan G-F 20) is built from cross-linked hylan A and hylan B, while HYALGAN® is a non-cross-linked sodium hyaluronate. Cross-linking extends joint residence time but changes the rheological profile, and clinicians who judge that a cross-linked avian formulation suits their patient mix will buy SYNVISC® on that clinical basis.

HYALGAN® vs SUPARTZ®

Of all the competing viscosupplements, SUPARTZ® is the closest to HYALGAN®: both are avian-derived sodium hyaluronate products requiring pre-treatment avian allergy screening, given over multi-injection weekly courses [4]. The two diverge mainly on molecular weight and manufacturer, HYALGAN® from Fidia Pharma at 500–730 kDa, SUPARTZ® from Bioventus at a higher range. Because the products are so similar, procurement teams sometimes buy SUPARTZ® and HYALGAN® together to compare specifications and pricing before standardizing on one.

HYALGAN® Safety Profile

HYALGAN® has a well-characterized safety profile supported by multiple controlled clinical trials. The most commonly reported adverse events are localized to the injection site. Transient pain, swelling, and warmth are consistent with any intra-articular procedure and generally resolve without intervention [1]. In the Altman and Moskowitz RCT, HYALGAN® was associated with fewer adverse reactions than continuous oral naproxen over the 26-week study period [1].

The critical label-based contraindication for HYALGAN® is known or suspected hypersensitivity to avian proteins, given its rooster-comb origin [4]. Patients with known allergies to poultry, eggs, or feathers should not receive HYALGAN® without careful pre-treatment risk assessment. Additional contraindications include active infection of the knee joint, skin disease or infection at the planned injection site, and known hypersensitivity to any formulation component [4]. The side effects of HYALGAN® injections are well-documented across its clinical evidence base, and its long-term efficacy and safety are well-characterized. Safety and effectiveness in pregnant women, lactating women, and children have not been established [4].

Buy HYALGAN® Wholesale Through Direct Doctor Supply

Clinics that buy HYALGAN® wholesale benefit from a supplier that pairs verified product with responsive procurement support. To buy HYALGAN® injection online in clinic quantities, or to discuss volume terms and shipping, teams can work directly with the Direct Doctor Supply support team before an order is placed. Aesthetic-focused practices that also stock HA products can buy HA dermal fillers within the same catalog, keeping orthopedic and cosmetic ordering on one platform. Availability is limited to qualified professionals, and shipping runs through documented channels with delivery timelines suited to clinical scheduling.

FAQs

What is HYALGAN®?

HYALGAN® is an FDA-approved avian-derived sodium hyaluronate viscosupplement manufactured by Fidia Pharma, supplied as a 20 mg/2 mL pre-filled syringe for intra-articular injection into the knee. It is indicated for the treatment of painful knee osteoarthritis in patients who have not adequately responded to conservative therapy and simple analgesics [4][5]. It is a medical device, not a steroid or analgesic drug.

How does HYALGAN® work?

HYALGAN® is injected directly into the knee joint, where it supplements naturally occurring hyaluronic acid in the synovial fluid. By restoring the lubricating and viscoelastic properties diminished by osteoarthritis, it aims to reduce the mechanical friction and discomfort associated with joint movement [1][4]. Its action is mechanical and biological rather than pharmacological.

What is the HYALGAN® J code?

J7321. This CMS-assigned J code is used for Medicare and insurance billing of HYALGAN® intra-articular injections on a per-dose basis. J7321 is among the most established codes in the viscosupplement billing category, reflecting HYALGAN®’s long history as an FDA-approved device in the US market.

Does Medicare cover HYALGAN® injections?

Coverage may be available when applicable Medicare viscosupplementation criteria for knee osteoarthritis are met, including documented failure of conservative non-pharmacological therapy and simple analgesics. Practitioners should verify current local coverage determinations and individual patient eligibility before initiating treatment, as coverage requirements vary and are subject to change.

Are HYALGAN® injections painful?

Mild discomfort is typical of any intra-articular injection. Patients may experience transient pressure or soreness during the procedure and briefly afterward. In the pivotal RCT, HYALGAN® was described as generally well tolerated, with injection-site reactions mild and transient [1]. Use of local anesthetic prior to injection is at the practitioner’s discretion.

How long does it take for HYALGAN® injections to work?

Onset of benefit varies between patients and is not immediate. The Altman and Moskowitz RCT demonstrated sustained pain reduction across multiple time points through 26 weeks of follow-up [1], and benefit often continues to develop after the injection course is complete. Practitioners should set appropriate patient expectations regarding the gradual nature of response.

HYALGAN® vs SUPARTZ® — what’s the difference?

Both are avian-derived sodium hyaluronate viscosupplements requiring pre-treatment avian allergy screening and administered over multi-injection weekly courses [4]. Primary differences lie in molecular weight range and manufacturer: HYALGAN® (500–730 kDa) is produced by Fidia Pharma, while SUPARTZ® operates at a higher molecular weight range and is manufactured by Bioventus. Selection typically comes down to clinical preference, institutional familiarity, and pricing.

Looking to buy HYALGAN® products?

Direct Doctor Supply offers HYALGAN® 20 mg/2 mL pre-filled syringes through a professional wholesale catalog for licensed practitioners and clinic procurement teams. Individual and bulk ordering options are available, with dedicated support staff, transparent pricing, and reliable delivery to hospitals, clinics, and healthcare facilities. Practitioners reviewing HYALGAN® injection reviews and clinical data before committing can purchase HYALGAN® online or explore volume pricing by browsing the catalog above or contacting the Direct Doctor Supply support team directly.

Citations and Resources about HYALGAN®

[1] Altman RD, Moskowitz R. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group. Journal of Rheumatology. 1998. https://pubmed.ncbi.nlm.nih.gov/9818665/

[2] Stitik TP, Issac SM, Modi S, Nasir S, Kulinets I. Effectiveness of 3 Weekly Injections Compared With 5 Weekly Injections of Intra-Articular Sodium Hyaluronate on Pain Relief of Knee Osteoarthritis or 3 Weekly Injections of Other Hyaluronan Products: A Systematic Review and Meta-Analysis. Archives of Physical Medicine and Rehabilitation. 2017. https://pubmed.ncbi.nlm.nih.gov/28232252/

[3] Jubb RW, Piva S, Beinat L, Dacre J, Gishen P. A one-year, randomised, placebo (saline) controlled clinical trial of 500-730 kDa sodium hyaluronate (Hyalgan) on the radiological change in osteoarthritis of the knee. International Journal of Clinical Practice. 2003. https://doi.org/10.1111/j.1742-1241.2003.tb10535.x

[4] National Library of Medicine, AccessGUDID. DEVICE: Hyalgan® Sodium Hyaluronate Pre-filled Syringe — 2mL. AccessGUDID. https://accessgudid.nlm.nih.gov/devices/M71389122072420A1

[5] U.S. Food and Drug Administration. Premarket Approval (PMA) P950027 and supplement records for HYALGAN. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P950027

All content on this website is intended for informational purposes and does not constitute medical advice.

Content prepared by Direct Doctor Supply’s editorial team.

Sourcing and accuracy for this page follow our Editorial Policy: claims are cross-checked against clinical literature, regulatory filings, and manufacturer specifications before anything is published.

SVG Logo Color cropped

info@directdoctorsupply.com

+1-800-325-7104

Book a MeetingTrack delivery
Trustpilot

Supported payment providers

Visa Mastercard American Express Google Pay Apple Pay

*Apple Pay and Google Pay are available via a personalized link provided by your account manager.

🔒 Transactions on this website meet strict PCI DSS compliance for your safety.

Product authenticity guaranteed: all products are sourced from licensed distributors and traceable by LOT number.

Company
  • About Us
  • FAQ
  • Contact Us
  • Referral Program
  • Sitemap
Follow Us
  • Facebook
  • Instagram
  • LinkedIn
Company
  • About Us
  • FAQ
  • Contact Us
  • Referral Program
Follow Us
  • Facebook
  • Instagram
  • Linkedin
Products
  • Anaesthetics
  • Body Sculpting
  • Botulinum Toxin
  • Needles and Cannula
  • Filler Removal
  • Dermal Fillers
  • Eyelash Enhancers
  • Fat Removal
  • Gynecology
  • Mesotherapy
  • Orthopaedic Injections
  • Peels and Masks
  • PRP Kits
  • Skincare
  • Threads
  • Weight Management
Products
  • Anaesthetics
  • Body Sculpting
  • Botulinum Toxin
  • Needles and Cannula
  • Filler Removal
  • Dermal Fillers
  • Eyelash Enhancers
  • Fat Removal
  • Gynecology
  • Mesotherapy
  • Orthopaedic Injections
  • Peels and Masks
  • PRP Kits
  • Skincare
  • Threads
  • Weight Management

All peptide products sold by Direct Doctor Supply are Research Use Only (RUO) and intended solely for laboratory and scientific research. They are not FDA-approved and not for human or veterinary use, clinical, diagnostic, or therapeutic purposes. By purchasing RUO materials, you confirm they will be handled by qualified personnel in a proper research setting and in compliance with regulations. Products must not be administered to humans or animals or represented as safe or effective for medical use. Use is at your own risk; Direct Doctor Supply assumes no liability for misuse or regulatory issues.

2026 Direct Doctor Supply All rights reserved.
Terms Of Use Privacy Policy Refund and Replacement Shipping & Delivery